- 英文名称
- Baloxavir
- 分子式
- C24H19F2N3O4S
- 分子量
- 483.49
- 中文别名
- 巴罗沙韦; 巴罗韦韦; (12aR)-12-[(11S)-7,8-二氟-6,11-二氢二苯并[b,e]噻庚英-11-基]-3,4,12,12a-四氢-7-羟基-1H-[1,4]恶嗪并[3,4-c]吡啶并[2,1-f][1,2,4]三嗪-6,8-二酮; (12aR)-12-[(11S)-7,8-二氟-6,11-二氢二苯并[b,e]噻庚英-11-基]-6,8-二氧代-3,4,6,8,12,12a-六氢-1H-[1,4]噁嗪并[3,4-c]吡啶并[2,1-f][1,2,4]三嗪-7-醇; (R)-12-((S)-7,8-二氟-6,11-二氢二苯并[b,e]噻吩-11-基)-7-羟基-3,4,12,12a-四氢-1H-[1,4]恶嗪[3,4-c]吡啶[2,1-f][1,2,4]三嗪-6,8-二酮; CPD2051; S-033447; (12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione; (R)-12-((S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione; (12aR)-12-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-ol; (12aR)-12-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
- 用途
- 生命科学;第三代抗流感化学药物;新型速效流感药物,用于治疗12岁以上、流感症状持续时间不超过48小时的急性流感患者(含奥司他韦耐药株和禽流感株),2019年扩大适应症至流感并发症高风险人群(12岁及以上,感染不超过48小时且无并发症)。